Vimala
Raghavendran vimala.raghavendran.wg11
@
wharton.upenn.edu Knox College, Galesburg, IL,
B.A., Magna Cum Laude, Phi Beta Kappa, Economics, 2002 Syracuse University, Syracuse, NY M.A., International Relations, 2004
An impactful opportunity in strategy or commercial operations within the life sciences industry.
Dr. Reddy’s Laboratories, Hyderabad, India
Strategy Intern, Summer 2010 Conducted strategic assessment for entry into over-the-counter pharma- ceutical market in India, leading to a change of course and further due diligence on recommended option.
PricewaterhouseCoopers, New York, NY Global Health Care Intern, Summer 2010 Analyzed data and conducted stake- holder interviews for international knowledge management assessment. Provided domain expertise for business development in health care in India and Middle East.
International Partnership for Microbicides, Silver Spring, MD Senior Policy Associate, 2008-2009 Policy Associate, 2005-2008
Resource Mobilization Associate, 2004-2005 Led industry-first studies to model cost-effectiveness that provided basis for IPM’s commercialization strategy. Managed $1.2M market research study on formulations in 4 countries by liaising with clinical and R&D teams. Designed and implemented a lobbying strategy, resulting in increased government funding of US$36M. Drafted proposals leading to awards of $33M.
Salomon Smith Barney, New York, NY Intern, 2001
Provided equity research support to private wealth team with $500M under management.
An opportunity to leverage my leader- ship experience, my bio-engineering entrepreneurial background and my interest in finance in a global biophar- maceutical or medical device company.
Novartis Vaccines and Diagnostics, Cambridge, MA
Global Marketing Associate, Global Public Health and Market Access, Summer 2010 Led interviews with KOLs and wide range of hospital specialists supplemented by secondary research to inform market segmentation, product positioning and drivers of economic value. Identified ideas to accelerate development allowing for 50% fewer enrollees in clinical trials and improved power for efficacy end points.
NeuroDerm, Nes-Ziona, Israel Senior Scientist and Chief Engineer, 2003-2009
Directed the company’s preclinical studies at the end of which NeuroDerm was awarded $480,000 grant from the Michael J. Fox Foundation for Parkinson’s Disease Research. Supervised due diligence process performed by VC resulting in NeuroDerm raising $2.5M.
Israel Defense Forces, Israel Major – Deputy Commander of a Regiment in the Armored Corps, 1999
Captain – Company Commander in the Armored Corps, 1998-1999 Led 60 soldiers in training and operations.
First Lieutenant – Brigade Operations Officer 1996-1998
Coordinated execution of complex military operations.
An opportunity to create unique values by leveraging my scientific knowledge and business skills.
SR One, Conshohocken, PA Intern, 2010-Present
Conduct scientific, management, commercial, and financial due diligence on investment opportunities involving clinical compounds, preclini- cal assets, and platform technologies across therapeutic areas. Developed investment strategy for potential investments in China.
Schering-Plough, Kenilworth, NJ Associate Principal Scientist, 2007-2009 Co-authored the dossier to obtain marketing approval from the U.S. and European health authorities for a Hepatitis C therapy for children, strengthening Schering-Plough’s position as a major player in the $3B anti-HCV drug global market. Collaborated with cross-functional teams to develop drug candidates in the therapeutic areas of oncology and rheumatology.
Abbott Laboratories, Abbott Park, IL Associate Research Investigator, 2007-2007 Senior Research Pharmacologist, 2005-2007 Led the clinical pharmacology activi- ties with a team of four for successful marketing approval of Humira as the first line treatment for rheumatoid arthritis in children. Applied novel quantitative approaches to predict the effect of Humira dosage change on drug efficacy and safety and saved the company $2M clinical development cost. Developed innovative analytics to support product differentiation strategy and customer segmentation.
Amir Reichman
amir.reichman.wg11@
wharton.upenn.edu Ben-Gurion University, Beer Sheva, Israel B.Sc., Biotechnology Engineering, 2004 M.Sc., Summa Cum Laude, Biotechnology Engineering, 2006
Aaron G. Ren, Ph.D.
aaron.ren.wg11@
wharton.upenn.edu Peking University, Beijing, China B.S., Genetics and Cell Biology, 1999 University of Washington, Seattle, WA Ph.D., Pharmaceutics, 2005
23
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40